Financial & competing interests disclosure
DYF So has received unrestricted research grants for physician-initiated studies from Sanofi-Aventis (Québec, Canada), Abbott Vascular (Québec, Canada) and Spartan Biosciences (Ontario, Canada). He has also received speaker honoraria from Eli Lilly (Ontario, Canada). The RAPID GENE and RAPID STEMI studies are funded by Spartan Biosciences. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.